Prostate Cancer

PROSTATE CANCER NEWS TIPS & FEATURES

Different Treatment Options Appear Equally Effective in Early Prostate Cancer

October 3rd, 2016

Different Treatment Options Appear Equally Effective in Early Prostate Cancer

Among men with early prostate cancer that is detected through prostate-specific antigen (PSA) testing, treatment with either surgery, radiation therapy, or monitoring until progression all […]


SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

September 28th, 2016

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent […]


Pass it On: It’s National Prostate Cancer Awareness Month

September 5th, 2016

Pass it On: It’s National Prostate Cancer Awareness Month

Prostate cancer is the most common type of cancer in men other than skin cancer, and the second leading cause of death.  The American Cancer […]


Midlife PSA Levels Correlate to Risk of Future Lethal Prostate Cancer

August 15th, 2016

Midlife PSA Levels Correlate to Risk of Future Lethal Prostate Cancer

A baseline prostate-specific antigen (PSA) level among men at midlife appears to be highly correlated with the risk of developing lethal prostate cancer within their […]


New Tool Helps Men Evaluate Watchful Waiting in Early Stage Prostate Cancer

August 10th, 2016

New Tool Helps Men Evaluate Watchful Waiting in Early Stage Prostate Cancer

Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer. […]


Cabozantinib Does Not Demonstrate Improvements in Advanced Prostate Cancer

July 26th, 2016

Cabozantinib Does Not Demonstrate Improvements in Advanced Prostate Cancer

In a recent study, the targeted agent cabozantinib did not demonstrate an improvement in outcomes compared to prednisone, among men with advanced prostate cancer. These […]


Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations

July 14th, 2016

Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations

Ever since inherited mutations in BRCA genes were first linked to breast and ovarian cancer two decades ago, this information has been used as a way to help empower […]


FDA Approves New Imaging Agent for Detection of Recurrent Prostate Cancer

June 13th, 2016

FDA Approves New Imaging Agent for Detection of Recurrent Prostate Cancer

The United States Food and Drug Administration (FDA) has approved Axumin (fluciclovine F 18), an radioactive agent, to be used in positron emission tomography (PET) […]


Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk

May 25th, 2016

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the […]


Addition of Radiation Improves Survival in High-Risk Prostate Cancer

May 18th, 2016

Addition of Radiation Improves Survival in High-Risk Prostate Cancer

The addition of radiation therapy to androgen-deprivation therapy among men with prostate cancer who are at a high risk of a cancer recurrence significantly improves […]


More News →